HIGHFDA DEVICE

International Life Sciences Recalls Artelon FlexBand Plus Augmentation Devices for Endotoxin Testing

International Life Sciences recalled Artelon FlexBand Plus augmentation devices after endotoxin testing failures. The recall affects devices with REF 41054 and REF 41057 distributed worldwide. Patients and healthcare providers must stop using the devices immediately and follow manufacturer instructions for recall return.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DEVICE
Recall date
February 6, 2026
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
February 6, 2026
Hazard Level
HIGH
Brand
International Life Sciences
Category
Health & Personal Care
Sold At
Unknown
Geographic Scope
1 states
At-Risk Groups
GENERAL, PREGNANT, INFANTS

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Medical Devices; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
International Life Sciences
Product type
Augmentation devices
Model numbers
REF 41054, REF 41057
Sold at
Unknown
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    February 6, 2026

  2. Reported by FDA DEVICE

    March 18, 2026

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Augmentation devices failed bacterial endotoxin testing.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact International Life Sciences or your healthcare provider for instructions. Notification method: Letter

About This Product

Artelon FlexBand Plus is an augmentation device used in certain clinical settings. Consumers may encounter these devices in surgical or rehabilitative contexts.

Why This Is Dangerous

Endotoxin testing failure can indicate bioburden and biocompatibility issues potentially affecting patient safety.

Industry Context

This recall is part of ongoing FDA-regulated medical device recalls focusing on endotoxin compliance.

Real-World Impact

Immediate cessation required. Potential delays in treatment and need for alternate devices or procedures.

Practical Guidance

How to identify if yours is affected

  1. Check deviceRef REF 41054 and REF 41057
  2. Verify Lot numbers A10010201 and A10010101
  3. Review distribution list for your facility

Where to find product info

Recall letters and FDA enforcement page Z-1555-2026

What timeline to expect

Refund or replacement timelines are not specified

If the manufacturer is unresponsive

  • Escalate to hospital risk management
  • File a complaint with FDA if company is unresponsive
  • Consult legal counsel if needed

How to prevent similar issues

  • Ensure endotoxin testing during device sourcing
  • Verify supplier recalls before implantation
  • Maintain updated medical device recall alerts

Documentation advice

Keep recall notices, record device identifiers, dates, and communications with supplier

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Product: Artelon FlexBand Plus. Ref: 41054 and 41057. Distribution: Worldwide, including US states listed and many countries. Recall date: 2026-02-06. Status: Active.

Reported Incidents

No specific injuries or incidents are reported in the provided data.

Key Facts

  • Worldwide distribution including US and numerous countries
  • Hazard: endotoxin testing failure
  • High hazard level

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERALPREGNANTINFANTSELDERLYPETS
Injury Types
POISONINGBURNELECTRICAL

Product Details

Model Numbers
REF 41054
REF 41057
Affected States
ALL
Report Date
March 18, 2026
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

Taro Pharmaceuticals Withdraws Diclofenac Sodium Gel Over Viscosity Issues

Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.

BEEKEEPER'S NATURALS USA
Microbial Contamination
Read more
Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more